Leonard Freedman, Ph.D., was named chief science officer at the Frederick National Laboratory for Cancer Research (Frederick, Maryland). He began his duties there in November after six years as the founding president of the Global Biological Standards Institute. In his role at FNL, Leonard provides internal scientific leadership and builds external partnerships and collaborations in science and technology development. His focus is on translating science into medicine to benefit patients suffering from AIDS, cancer and emerging health challenges. Previous positions also include vice dean for research and professor of biochemistry and molecular biology at Jefferson Medical College, Thomas Jefferson University, as well as top executive positions at the pharmaceutical companies Wyeth and Merck. He also was a member and professor of cell biology and genetics at Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical College. There, he and his laboratory made decisive discoveries in the area of nuclear hormone receptor structure and function. Leonard is widely published and has served on influential scientific review panels and editorial boards. For 10 years he was editor of Molecular and Cellular Biology. At K, he majored in biology; he earned his Ph.D. in molecular genetics from the University of Rochester.